A new roundtable discussion moderated by Nataliya Uboha, MD, PhD, focused on current treatment considerations for gastric cancer, GEJC, and ESCC, as well as relevant clinical trial data from ASCO GI 2025. Dr. Uboha was joined by Zev Wainberg, MD, MSc; Suneel Kamath, MD; and Sunnie Kim, MD.

At ASCO GI 2025, Boris Pasche, MD, PhD, of Karmanos Cancer Institute gave an overview of the TheraBionic P1 device and how it works as a systemic targeted therapy for advanced hepatocellular carcinoma.

Yelena Janjigian, MD, chief of the Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center, is joined by Bassam Sonbol, MD, Mayo Clinic; Sakti Chakrabarti, MD, University Hospitals; Samuel Cytryn, MD, Memorial Sloan Kettering Cancer Center; and Mariela Blum Murphy, MD, MD Anderson Cancer Center, for a roundtable discussion on the upper GI treatment landscape.